With the use of an oral lipid challenge, we discovered that a single dose of acyl-GIP blunts hypertriglyceridemia through mechanisms of plasma lipid clearance into BAT via increases in lipoprotein lipase (LPL) activity. This evidence concerns the gene LPL and hypertriglyceridemia.